Publications by authors named "James Stec"

Claim this Profile
S
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer.
Ursula A Matulonis, Ignace Vergote, Kathleen N Moore, Lainie P Martin, Cesar M Castro, James Stec

Gynecol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer.
Debra L Richardson, Kathleen N Moore, Ignace Vergote, Lucy Gilbert, Lainie P Martin, James Stec

Gynecol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer.
Clinton Yam, Gaiane M Rauch, Tanbin Rahman, Meghan Karuturi, Elizabeth Ravenberg, James Stec

Invest New Drugs· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Folate Receptor α-Targeted Zr-M9346A Immuno-PET for Image-Guided Intervention with Mirvetuximab Soravtansine in Triple-Negative Breast Cancer.
Gyu Seong Heo, Lisa Detering, Hannah P Luehmann, Tina Primeau, Yi-Shan Lee, James Stec

Mol Pharm· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the predictive accuracy of DNA array-based multigene classifiers across cDNA arrays and Affymetrix GeneChips.
James Stec, Jing Wang, Kevin Coombes, Mark Ayers, Sebastian Hoersch

J Mol Diagn· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer molecular subtypes respond differently to preoperative chemotherapy.
Roman Rouzier, Charles M Perou, W Fraser Symmans, Nuhad Ibrahim, Massimo Cristofanilli, James Stec

Clin Cancer Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer.
Roman Rouzier, Radhika Rajan, Peter Wagner, Kenneth R Hess, David L Gold, James Stec

Proc Natl Acad Sci U S A· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy.
Lynn C Hartmann, Karen H Lu, Gerald P Linette, William A Cliby, Kimberly R Kalli, James Stec

Clin Cancer Res· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapies for cancer 2004.
Jeffrey S Ross, David P Schenkein, Robert Pietrusko, Mark Rolfe, Gerald P Linette, James Stec

Am J Clin Pathol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics.
Jeffrey S Ross, David P Schenkein, Oscar Kashala, Gerald P Linette, James Stec

Adv Anat Pathol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy in breast cancer: the HER-2/neu gene and protein.
Jeffrey S Ross, Jonathan A Fletcher, Kenneth J Bloom, Gerald P Linette, James Stec

Mol Cell Proteomics· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer biomarkers and molecular medicine: part II.
Jeffrey S Ross, Gerald P Linette, James Stec, Edwin Clark, Mark Ayers

Expert Rev Mol Diagn· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy.
Jeffrey S Ross, Jonathan A Fletcher, Gerald P Linette, James Stec, Edward Clark

Oncologist· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER-2/neu testing in breast cancer.
Jeffrey S Ross, Jonathan A Fletcher, Kenneth J Bloom, Gerald P Linette, James Stec

Am J Clin Pathol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA ploidy and cell cycle analysis in breast cancer.
Jeffrey S Ross, Gerald P Linette, James Stec, Merrill S Ross, Shahgul Anwar

Am J Clin Pathol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical application of cDNA microarrays in oncology.
Lajos Pusztai, Mark Ayers, James Stec, Gabriel N Hortobágyi

Oncologist· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer biomarkers and molecular medicine.
Jeffrey S Ross, Gerald P Linette, James Stec, Edwin Clark, Mark Ayers

Expert Rev Mol Diagn· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.
Lajos Pusztai, Mark Ayers, James Stec, Edward Clark, Kenneth Hess

Clin Cancer Res· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma.
W Fraser Symmans, Mark Ayers, Edwin A Clark, James Stec, Kenneth R Hess

Cancer· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global gene expression changes during neoadjuvant chemotherapy for human breast cancer.
Thomas A Buchholz, David N Stivers, James Stec, Mark Ayers, Edward Clark

Cancer J· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis